Clinical Drug Experience Knowledgebase

Acute Coronary Syndrome (Phase 4)

Afibrinogenemia (Phase 3)

Angina, Unstable (Phase 4)

Bronchial Hyperreactivity (Phase 4)

Bronchitis (Phase 3)

Bronchitis, Chronic (Phase 3)

Cough (Phase 4)

Diabetes Mellitus (Phase 3)

Diabetes Mellitus, Type 2 (Phase 3)

Diabetic Nephropathies (Phase 4)

Gastroesophageal Reflux (Phase 4)

HIV Infections (Phase 3)

Hyperglycemia (Phase 4)

Infarction (Phase 4)

Influenza, Human (Phase 2)

Kidney Diseases (Phase 4)

Lung Diseases (Phase 4)

Lung Diseases, Obstructive (Phase 4)

Lymphoma (Phase 2)

Lymphoma, T-Cell (Phase 2)

Lymphoma, T-Cell, Peripheral (Phase 2)

Melanoma (Phase 2)

Metabolic Syndrome (Phase 3)

Multiple Myeloma (Phase 2)

Myocardial Infarction (Phase 4)

Neoplasms, Plasma Cell (Phase 2)

Non-ST Elevated Myocardial Infarction (Phase 4)

Pancreatic Neoplasms (Phase 2)

Pheochromocytoma (Phase 4)

Pulmonary Disease, Chronic Obstructive (Phase 4)

Respiratory Insufficiency (Phase 3)

Sarcoma, Clear Cell (Phase 2)

ST Elevation Myocardial Infarction (Phase 4)

Syndrome (Phase 4)

Thrombosis (Phase 3)